id,question,opa,opb,opc,opd,cop,choice_type,exp,subject_name,topic_name,dataset_split,llama3.3-70b_response,llama3.3-70b_answer,llama3.3-70b_response_parsed,correct_answer,llama3.3-70b_accuracy,llama3.3-70b_bert_scores,llama3.3-70b_bart_scores,llama3.3-70b_alignscore,llama3.3-70b_rougeL,llama3.3-70b_meteor,correct_accuracy,llama3.3-70b_weighted_normalized_score
a3da135a-a6a2-4e1c-8823-8ab0913f5668,"A patient presented to emergency with overdose some drug. There were increased salivation and increased bronchial secretions. On examination, blood pressure was 88/60 mmHg. RBC esterase level is 50. What should be the treatment of this person?",Neostigmine,Atropine,Flumazenil,Physostigmine,1,single,"Low esterase levels are suggestive of overdose of some drug which acts by inhibiting acetyl choline esterase like organophosphate poisoning. Inhibition of choline esterase results In increased amount of Ach at synapse, so poisoning or overdose results in cholinergic symptoms like salivation, lacrimation, urination, emesis, increased bronchial secretions, reduction in blood pressure.So treatment Of choice is Atropine. Atropine -It is highly effective in counter-acting the muscarinic symptoms, but higher doses are required to antagonize the central effects. It does not reverse peripheral muscular paralysis which is a nicotinic action. All cases of anti-ChE (carbamate or organophosphate) poisoning must be promptly given atropine2 mg i.v. repeated every 10 min till dryness of mouth or other signs of atropinization appear (upto 200 mg has been administered in a day). Continued treatment with maintenance doses may be required for 1-2 weeks. Neostigmine and physostigmine worsens the signs and symptoms as these also act by inhibiting choline esterase. Physostigmine and flumazenil are respectively used for Atropine and benzodiazepines poisoning.",Pharmacology,AIIMS 2019,validation,"{
    ""Correct answer"": ""B"",
    ""Reasoning"": ""The patient's symptoms, such as increased salivation and bronchial secretions, suggest organophosphate or carbamate poisoning, which inhibits acetylcholinesterase. The low RBC esterase level confirms this. Atropine is the correct treatment, as it counteracts muscarinic effects of acetylcholine, alleviating symptoms.""
}",B,"The patient's symptoms, such as increased salivation and bronchial secretions, suggest organophosphate or carbamate poisoning, which inhibits acetylcholinesterase. The low RBC esterase level confirms this. Atropine is the correct treatment, as it counteracts muscarinic effects of acetylcholine, alleviating symptoms.",B,1.0,0.6990064248288923,0.8310570582010542,0.9074665237789554,0.27692307692307677,0.22373369726851425,1,0.5876373562000985
a570d3c3-865a-41b6-8e21-dccbf7feec4c,"A patient from,nqh-eastern states was diagnosed to have infection with P. falciparum malaria. What is the most appropriate drug for this patient?",Aemether plus lumefantrine,Sulfadoxine plus pyrimethamine,Chloroquine,Mefloquine,0,single,"Ans: A. Aemether plus lumefantrineRef: <a href="" Combination Therapy (ACT) should be given to all the confirmed P. falciparum cases.</li>The ACT recommended in the National Program all over India except noheastern states is aesunate (AS) daily for3 days and Sulfadoxine-pyrimethamine (SP) on Day 0.Noheastern states presently recommended ACT in national drug policy is fixed dose combination of Aemether-lumefaritrine.Hence, the clear-cut answer of this question is Aemether plus lumefantrine.",Pharmacology,,validation,"{
    ""Correct answer"": ""A"",
    ""Reasoning"": ""Artemether plus lumefantrine is the most appropriate choice for P. falciparum malaria due to its high efficacy and rapid action, especially in regions with chloroquine resistance, making it a preferred treatment option.""
}",A,"Artemether plus lumefantrine is the most appropriate choice for P. falciparum malaria due to its high efficacy and rapid action, especially in regions with chloroquine resistance, making it a preferred treatment option.",A,1.0,0.5694520035795712,0.7230339427765571,0.0021749591951229796,0.2717469446441408,0.21929642111801795,1,0.357140854262682
e7f023ea-2147-47d3-9f2a-61fb60a900be,Which of these drugs is an antidote for fibrinolytic therapy?,Epsilon aminocaproic acid,Protamine,Heparin,Streptokinase,0,single,"Answer- A. Epsilon aminocaproic acidEpsilon aminocaproic acid is an antidote for fibrinolytic therapy. Epsilon-aminocaproic qcid is a synthetic inhibitor of theplasmin-plasminogen system. It is the only potent antifibrinolylic agent, which is commercially available.""Aminocaproic acid is a lysine analog that competes for lysine binding sites on plasminogen and plasmin, blocking theinteraction of plasmin with fibrin.Fibrinolytic overdose - Epsilon Amino Caproic Acid (EACA)",Pharmacology,,validation,"{
    ""Correct answer"": ""A"",
    ""Reasoning"": ""Epsilon aminocaproic acid is an antidote for fibrinolytic therapy as it inhibits plasminogen activators, thereby stopping the breakdown of fibrin clots. It reverses the effects of fibrinolytic agents like streptokinase.""
}",A,"Epsilon aminocaproic acid is an antidote for fibrinolytic therapy as it inhibits plasminogen activators, thereby stopping the breakdown of fibrin clots. It reverses the effects of fibrinolytic agents like streptokinase.",A,1.0,0.7457444276086147,0.9947389021171407,0.4293202609841175,0.7217675941080197,0.3944496919004113,1,0.6572041753436608
e881fcb0-a4f2-45ed-97cf-c53045f98e30,Absorption of which of the following drugs is increased after a fatty meal?,Amphotericin B,Griseofulvin,Ampicillin,Aspirin,1,single,"Ans: B. Griseofulvin (Ref: Goodman Gilman I2/e p1585; Katzung 13/e p632, 12/e p855,. KUT 7/e p790, 6/e p760)The oral administration of a 0.5 g dose of griseofulvin produces peak plasma concentrations of 1ug/mL in 4 hours.Improved drug absorption along with a fatty meal.Drug Absorption Reduced/Delayed by FoodDrug Absorption increased by foodAmpicillindegAspirindegAtenololdegAzithromycindegCaptoprildegCefaclorCephalexinCiprofloxacinDidanosineIndinavirdegIsoniazidaLoratidineNaficillinPenicillin G or VdegPhenobarbitaldegPhenytoindegRifampindegSucralfatedegTetracyclinedegDoxycyclinedegAtovaquonedegCarbamazepinedegChlohiazidedegCefuroximedegClofaziminedegDiazepamdegErythromycin GanciclovirdegHydrochlorothiazidedegItraconazoleaLithiumdegLovastatinMethylphenidateMetoprololdegNelfinavirNitrofurantoinPropranololdegPropoxypheneRitonavirdegSaquinavirdegSpironolactonedeg*Hydralazinedeg",Pharmacology,,validation,"{
    ""Correct answer"": ""B"",
    ""Reasoning"": ""Griseofulvin's absorption is increased after a fatty meal due to its lipophilic nature, allowing better solubilization in bile salts and micellar formation, enhancing its absorption in the small intestine.""
}",B,"Griseofulvin's absorption is increased after a fatty meal due to its lipophilic nature, allowing better solubilization in bile salts and micellar formation, enhancing its absorption in the small intestine.",B,1.0,0.0382752879849431,0.6860136165050669,0.02966683962576299,0.29976209357652644,0.20435185279828402,1,0.25161393809811666
da27e783-4c0b-4621-bc3d-938a109d8425,Use of lithium during pregnancy increases the risk of development of which of the following malformations in the baby?,Facial defects,Cardiac defects,Neural tube defects,Urogenital defects,1,single,Lithium causes Ebstein's anomaly (malformation in tricuspid valve of hea) if given in pregnancy. Other side effects of lithium includes: Leucocytosis I Tremors (most common adverse effect) Hypothyroidism Increase Urine (polyuria) Mothers (avoided in pregnancy).,Pharmacology,AIIMS 2018,validation,"{
    ""Correct answer"": ""B"",
    ""Reasoning"": ""Lithium use during pregnancy is associated with an increased risk of cardiac malformations in the baby, particularly Ebstein's anomaly, a congenital heart defect. This is due to lithium's potential to affect cardiac development during embryogenesis.""
}",B,"Lithium use during pregnancy is associated with an increased risk of cardiac malformations in the baby, particularly Ebstein's anomaly, a congenital heart defect. This is due to lithium's potential to affect cardiac development during embryogenesis.",B,1.0,0.6136108014405838,0.680057419473717,0.35498538427502124,0.3319283456269758,0.25277641927678984,1,0.4466716740186175
2dd59aba-38c0-4aff-a000-1bcb640254ff,"Drug adveisement letter is a necessary component of each drug formulation and contains various information about the drug like drug dosing, frequency and half-life. Which of the following information need not be given in the drug adveisement letter?",Research papers and other aicles proving efficacy of the drug,Date of expiry of the drug,"Rare, but serious life threatening adverse-effects","Common, not so serious adverse-effects",1,single,"Ans: B. Date of expiry of the drug(Ref Goodman Gilman 12/e p1883; Manual of Experimental and Clinical Pharmacology/p 345).Date of drug expiry need not to be given in drug adveisement letter.Regulated according to The Federal Food, Drug, and Cosmetic Act.Amended (Food and Drug Administration Modernization Act of 1997).Permits use of print & television adveising for prescription drugs.Drug adveisements:Contain summary information relating to side effects, contraindications & effectiveness.Current adveising regulations:Specify that this information disclosure needs to include all risk information in a product's approved labeling or must direct consumers to healthcare professionals to obtain this information.Print adveisements:Include reprinting of risk-related sections of product's approved labeling (package inse).Television adveising:Not includes reprinting of risk-related.Note:Adveisements cannot be false or misleading or omit material facts.Must present fair balance between effectiveness & risk information.",Pharmacology,,validation,"{
    ""Correct answer"": ""A"",
    ""Reasoning"": ""Research papers and articles are not typically included in drug advertisement letters. Instead, they are usually found in scientific journals or provided upon request. The letter focuses on key information like dosage, frequency, and side effects, making option A the correct choice.""
}",A,"Research papers and articles are not typically included in drug advertisement letters. Instead, they are usually found in scientific journals or provided upon request. The letter focuses on key information like dosage, frequency, and side effects, making option A the correct choice.",B,0.0,0.4347941284500773,0.497544955943472,0.05585652398226599,0.2564102564102564,0.1711819777449218,1,0.28315756850619866
58ffad4a-5613-4d26-88b2-a4bb2ce2b9e6,Which of the following drugs can be stopped abruptly without any withdrawal symptoms?,Esctilaopram,Fluoxetine,Fluvoxamine,Seraline,1,single,Answer- B. FluoxetineFluoxetine has the lowest incidence of discontinuation syndrome among several antidepressants including paroxetin and venlafaxine. The longer half life of fluoxetine will avoid any withdrawal symptoms because this medication effectively tapers itself from the patient's system over a few days.,Pharmacology,,validation,"{
    ""Correct answer"": ""B"",
    ""Reasoning"": ""Fluoxetine has a long half-life and active metabolite, allowing for abrupt cessation without significant withdrawal symptoms, unlike other SSRIs which can cause discontinuation syndrome.""
}",B,"Fluoxetine has a long half-life and active metabolite, allowing for abrupt cessation without significant withdrawal symptoms, unlike other SSRIs which can cause discontinuation syndrome.",B,1.0,0.7470005915689796,0.8234656245342271,0.5451236683541288,0.3563348416289592,0.3209218489696809,1,0.5585693150111951
3e4d2174-1e88-4652-9aed-78e71215ffe8,Vitamin D toxicity is treated with,Chloroquine,Hydroxycholoquine,Dexamethasone,Ketoconazole,2,single,"Ans. C. Dexamethasone* Dexamethasone is used in the treatment of hypercalcemia due to vitamin D toxicity. Glucocoicoid (Dexamethasone, prednisolone etc) therapy will decrease plasma calcium levels by blocking the action of vitamin D(1,25 D) which results in reduced intestinal calcium absorption and increased urinary excretion of calcium. * Other drugs like chloroquine and hydroxychloroquine are less effective in treating hypercalcemia due to vitamin D toxicity.",Pharmacology,,validation,"{
    ""Correct answer"": ""D"",
    ""Reasoning"": ""Vitamin D toxicity is treated with Ketoconazole, as it inhibits the conversion of 25-hydroxyvitamin D to its active form, 1,25-dihydroxyvitamin D, thus reducing vitamin D's toxic effects.""
}",D,"Vitamin D toxicity is treated with Ketoconazole, as it inhibits the conversion of 25-hydroxyvitamin D to its active form, 1,25-dihydroxyvitamin D, thus reducing vitamin D's toxic effects.",C,0.0,0.6266286103485951,0.7089554662945411,0.062358944195244764,0.6494845360824741,0.2735441813516299,1,0.464194347654497
6bce210a-7174-4c76-b1f0-9bc3f5c835fc,CYP50 inhibition is least by:,Pantoprazole,Rabeprazole,Lansoprazole,Omeprazole,1,single,"Ans: B. Rabeprazole(Ref: Goodman Gilman 12/e p1990; Katzung131e p1060, 12/e p1089; KDT 7/e p653).Rabeprazole:Exclusively metabolized by CYP2C19 and does not cause any inhibition of CYP450.Highest efficacy.Lansoprazole - Most potent.Rabeprazole & pantoprazole have no significant drug interactions.The FDA has issued a warning about a potentially impoant adverse interaction between clopidogrel and proton pump inhibitors.Proton pump inhibitors should be prescribed to patients taking clopidogrel only if they have an increased risk of gastrointestinal bleeding or require them for chronic gastro-esophageal reflux or peptic ulcer disease, in which case agents with minimal CYP2C19 inhibition (pantoprazole or rabeprazole) are preferred",Pharmacology,,validation,"{
    ""Correct answer"": ""A"",
    ""Reasoning"": ""Pantoprazole is known to have the least effect on CYP2C19 and CYP3A4 enzymes compared to other proton pump inhibitors. This makes it less likely to inhibit CYP450 enzymes, including the specific concern of CYP2C19 often implied in such questions, thus having the least inhibition among the options provided.""
}",A,"Pantoprazole is known to have the least effect on CYP2C19 and CYP3A4 enzymes compared to other proton pump inhibitors. This makes it less likely to inhibit CYP450 enzymes, including the specific concern of CYP2C19 often implied in such questions, thus having the least inhibition among the options provided.",B,0.0,0.5337705208495233,0.7514687941675132,0.1224267847857921,0.3461538461538461,0.18618468882883402,1,0.38800092695710175
3b150083-1a5e-49ef-bc36-41a06b677b32,Major aim of phase 1 clinical trials is:,Safety,Efficacy,Dose,Pharmacokinetics,2,single,"Phase 1 clinical trial : It is first phase in humans. It is conducted mainly on healthy volunteers. In drugs with serious adverse effects and where alternative treatment is not available, phase 1 can be conducted on patients also. Major aim is to know the maximum tolerable dose (MTD). The aim of phase 1 trials should be marked as MTD > Dose > Pharmacokinetics > Safety",Pharmacology,AIIMS 2018,validation,"{
    ""Correct answer"": ""A"",
    ""Reasoning"": ""The major aim of phase 1 clinical trials is to assess the safety of a new drug in humans. This phase involves a small number of volunteers and focuses on evaluating the drug's tolerance, pharmacokinetics, and potential side effects to ensure safety.""
}",A,"The major aim of phase 1 clinical trials is to assess the safety of a new drug in humans. This phase involves a small number of volunteers and focuses on evaluating the drug's tolerance, pharmacokinetics, and potential side effects to ensure safety.",C,0.0,0.8700097939800958,0.8836566913544166,0.6462476803269055,0.6461538461538461,0.3784525150472548,1,0.6849041053725038
81ba27b9-0517-444f-b592-db6a7f23c69c,Acetazolamide is given to a patient of angle closure glaucoma. It is a non-competitive inhibitor of carbonic anhydrase enzyme. Which of the following should be the effect of this drug?,Decrease in Vmax,A.Decrease in Km,Increase in both Km and Vmax,No change in Vmax,0,multi,"* Enzyme inhibition is of 3 types: Type of inhibition Km Vmax Competitive inhibition Increases No change Non competitive inhibition No change Decreases Uncompetitive inhibition Decreases Decreases * In question non competitive inhibitor is given, so answer is decrease in Vmax.",Pharmacology,AIIMS 2018,validation,"{
    ""Correct answer"": ""A"",
    ""Reasoning"": ""Acetazolamide is a non-competitive inhibitor of carbonic anhydrase. Non-competitive inhibitors decrease the Vmax (maximum velocity) of the enzyme reaction without affecting the Km (Michaelis constant), which is the binding affinity of the enzyme for its substrate. This results in a decrease in the enzyme's ability to convert substrate to product, effectively reducing the reaction rate.""
}",A,"Acetazolamide is a non-competitive inhibitor of carbonic anhydrase. Non-competitive inhibitors decrease the Vmax (maximum velocity) of the enzyme reaction without affecting the Km (Michaelis constant), which is the binding affinity of the enzyme for its substrate. This results in a decrease in the enzyme's ability to convert substrate to product, effectively reducing the reaction rate.",A,1.0,0.47373458294484233,0.599356996802591,0.13626113852351526,0.4496431403647898,0.39763400953459166,1,0.4113259736340661
e7278113-c555-4128-a8df-cbd10ca7833f,"A patient is administered 200 mg of a drug. 75 mg of the drug is eliminated from the body in 90 minutes. If the drug follows first order kinetics, how much drug will remain after 6 hours?",12.5 mg,25 mg,30 mg,50 mg,2,single,Answer- C. 30 mgDrug remains in the body at the end of 4th 90 minutes (6 hours) : 48.7 -18.3 = 30.4 (Approx. 30 mg),Pharmacology,,validation,"{
    ""Correct answer"": ""A"",
    ""Reasoning"": ""For a first-order kinetic process, the rate of elimination is proportional to the amount of drug present. Given that 75mg is eliminated in 90 minutes from a 200mg dose, this indicates a half-life. To find the remaining amount after 6 hours, calculate the half-life: if 75mg is eliminated in 90 minutes from 200mg, the half-life (t1/2) is 90 minutes because 200mg - 75mg = 125mg, which is roughly half of 200mg considering first-order kinetics approximations. Then, calculate how many half-lives pass in 6 hours: 6 hours = 360 minutes, 360 minutes / 90 minutes per half-life = 4 half-lives. After 4 half-lives, 200mg / 2^4 = 200mg / 16 = 12.5mg remain.""
}",A,"For a first-order kinetic process, the rate of elimination is proportional to the amount of drug present. Given that 75mg is eliminated in 90 minutes from a 200mg dose, this indicates a half-life. To find the remaining amount after 6 hours, calculate the half-life: if 75mg is eliminated in 90 minutes from 200mg, the half-life (t1/2) is 90 minutes because 200mg - 75mg = 125mg, which is roughly half of 200mg considering first-order kinetics approximations. Then, calculate how many half-lives pass in 6 hours: 6 hours = 360 minutes, 360 minutes / 90 minutes per half-life = 4 half-lives. After 4 half-lives, 200mg / 2^4 = 200mg / 16 = 12.5mg remain.",C,0.0,0.4941691295647615,0.5907201603798288,0.11715921144397297,0.2749590834697217,0.5050120501218298,1,0.396403926996023
a5d733b4-18d3-468c-8aaa-bbcb66cbb07e,Adverse effects of salbutamol are all except,Tremors,Tachycardia,Hypoglycemia,Hypokalemia,2,multi,Salbutamol is a beta 2 agonist. Adverse effects of beta 2 agonists: Tremors Tachycardia Tolerance Hypokalemia (by enhancing potassium uptake into muscles) Hypoxia Hyperglycemia (by stimulating glycogenolysis and gluconeogenesis) Note: Tolerance occurs to only long acting beta 2 agonists .,Pharmacology,AIIMS 2018,validation,"{
    ""Correct answer"": ""C"",
    ""Reasoning"": ""Salbutamol is a beta-2 agonist, commonly causing tremors, tachycardia, and hypokalemia. However, it typically causes hyperglycemia due to glycogenolysis and gluconeogenesis, not hypoglycemia.""
}",C,"Salbutamol is a beta-2 agonist, commonly causing tremors, tachycardia, and hypokalemia. However, it typically causes hyperglycemia due to glycogenolysis and gluconeogenesis, not hypoglycemia.",C,1.0,1.0,0.9767827468906024,0.7812343071850198,1.0,0.5330314056787054,1,0.8582096919508654
100d2a31-8f28-4500-99c9-67690fe15625,Ganglionic transmission is mediated by:,Presynaptic alpha-receptors,Postsynaptic beta-receptors,Postsynaptic dopaminergic receptors,Postsynaptic nicotinic receptors,3,single,"Ans: D .Postsynaptic nicotinic receptors(Ref: Goodman Gilman 13/e p108, 12Ie p255; Katzung 13Ie p108, 12/e p98).Ganglionic transmission is mediated by nicotinic receptors present post-synaptically.Nicotinic acetylcholine (ACh) receptor mediates neurotransmission post-synaptically at the neuromuscular junction and peripheral autonomic ganglia.In CNS, controls release of neurotransmitters from presynaptic sites.The receptor is called the nicotinic acetylcholine receptor - Due to both alkaloid nicotine & neurotransmitter ACh can stimulate the receptor.",Pharmacology,,validation,"{
    ""Correct answer"": ""D"",
    ""Reasoning"": ""Ganglionic transmission is mediated by postsynaptic nicotinic receptors. Nicotinic acetylcholine receptors are found in the autonomic ganglia and are responsible for transmitting signals from preganglionic neurons to postganglionic neurons, facilitating sympathetic and parasympathetic nervous system functions.""
}",D,"Ganglionic transmission is mediated by postsynaptic nicotinic receptors. Nicotinic acetylcholine receptors are found in the autonomic ganglia and are responsible for transmitting signals from preganglionic neurons to postganglionic neurons, facilitating sympathetic and parasympathetic nervous system functions.",D,1.0,0.6700288676452691,0.9834177071812098,0.7889189775815826,0.6669019054340155,0.28130600519452414,1,0.6781146926073203
6e09a527-f1c4-4c9b-973b-aa93392f3f75,"One of the many mechanisms of adverse events is its increased binding to secondary targets, usually proteins. With respect to the primary target, the secondary target:",Should be present in the same tissue as the primary target,Should have similar binding sites,Should have absolutely identical secondary structure,Should have a similar primary structure,1,multi,Ans. b. Should have similar binding sites (Ref: vvww'plosone'org)Secondary site compared to the primary site has the same sequence of binding site.,Pharmacology,,validation,"{
    ""Correct answer"": ""B"",
    ""Reasoning"": ""The correct answer is B, as the secondary target should have similar binding sites to the primary target for the drug to exhibit adverse effects through increased binding, a concept related to the principle of cross-reactivity in Pharmacology.""
}",B,"The correct answer is B, as the secondary target should have similar binding sites to the primary target for the drug to exhibit adverse effects through increased binding, a concept related to the principle of cross-reactivity in Pharmacology.",B,1.0,0.6462162300547328,0.569967272670095,0.3003913122667891,0.8329326923076925,0.8199663735849854,1,0.6338947761768589
c1069842-8261-4a97-b1bb-5faeaacc6435,"Patient is a known case of epilepsy, taking levetiracetam 1 gm BD. He is now seizure free from 2 years but he developed agitation and anger issues interfering with day to day activities as a result of the drug intake. What should be the next best step?",Stop levetiracetam and sta on a different antiepileptic,Discontinue the drug as he is seizure free,Slowly taper the drug over next 6 months,Continue levetiracetam since a 5-year seizure free interval is needed,2,multi,"Answer- C. Slowly taper the drug over next 6 monthsStopping or switching an antiepileptic is based on seizure free period & compliance or adverse effects of the drug.Withdrawal of therapy should be gradual over 2-3 monlhs, in the question 6 months. Anti-epileptic drug therapy shouldnever he stopped abruptly. Even if new drug is to be added/replaced, the previous drug should be gradually stoppedotherwise it can lead to breakthrough seizures.",Pharmacology,,validation,"{
    ""Correct answer"": ""A"",
    ""Reasoning"": ""The patient is experiencing agitation and anger issues, likely a side effect of levetiracetam. Stopping the drug may not be the best option as it has controlled seizures. The next best step is to stop levetiracetam and start a different antiepileptic to manage seizures while alleviating the side effects.""
}",A,"The patient is experiencing agitation and anger issues, likely a side effect of levetiracetam. Stopping the drug may not be the best option as it has controlled seizures. The next best step is to stop levetiracetam and start a different antiepileptic to manage seizures while alleviating the side effects.",C,0.0,0.5768145575063708,0.6489378329496673,0.0732138469129909,0.48061029879211703,0.36767540123090503,1,0.4294503874784102
bb46d4ce-440a-4cea-ab6f-75ce99cdd3aa,Dapsone is used for treatment of bacterial and fungal infections as well as for immunomodulatory actions. What is mechanism of dapsone for these indication?,Inhibition of cell wall synthesis,Inhibition of ergosterol in cell membranes,Inhibition of protein synthesis,Competition with PABA in folic acid synthesis,3,multi,"Sulfonamides (including Dapsone and PAS) : Competitively inhibit folic acid synthase enzyme as these are PABA analogues. Trimethoprim, Pyrimethamine : Inhibit Dihydro folate reductase enzyme (DHFRase). Inhibition of ergosterol in cell membrane (in fungus and leishmania): Amphotericin B.",Pharmacology,AIIMS 2018,validation,"{
    ""Correct answer"": ""D"",
    ""Reasoning"": ""Dapsone works by competing with para-aminobenzoic acid (PABA) in the folic acid synthesis pathway, thus inhibiting bacterial growth. This is its primary mechanism for antibacterial effects, and it also contributes to its immunomodulatory and antifungal properties.""
}",D,"Dapsone works by competing with para-aminobenzoic acid (PABA) in the folic acid synthesis pathway, thus inhibiting bacterial growth. This is its primary mechanism for antibacterial effects, and it also contributes to its immunomodulatory and antifungal properties.",D,1.0,0.447234389078968,0.7239101019538383,0.22941821363658577,0.3319283456269758,0.3299627357664735,1,0.41249075721256834
6d426ea7-e119-4b5f-be99-1e36084c332c,All are topical hemostatic agents except?,Bone wax & patty,HemCon bandage,Quikclot,Fixclot,3,multi,"Ans. D. Fixclot Topical hemostatic agents are used when surgical hemostasis is inadequate or impractical. The majority of routine, elective operations are performed in patients with normal hemostasis and with minimal blood loss.The two main categories of topical hemostatic agents are physical agents, which promote hemostasis using a passive substrate, and biologically active agents, which enhance coagulation at the bleeding site",Pharmacology,,validation,"{
    ""Correct answer"": ""A"",
    ""Reasoning"": ""Bone wax and patty are not typically used as topical hemostatic agents, but rather as intraoperative hemostatic agents, applied directly to bleeding bone surfaces. The other options are topical agents.""
}",A,"Bone wax and patty are not typically used as topical hemostatic agents, but rather as intraoperative hemostatic agents, applied directly to bleeding bone surfaces. The other options are topical agents.",D,0.0,0.7686221410620439,0.611365617256047,0.2628352179855397,0.3687290969899664,0.3305244120311714,1,0.46841529706495366
1b18ac4d-8101-48f1-bcc9-b53391c550ab,Acetazolamide is given to a patient of angle closure glaucoma. It is a non- competitive inhibitor of carbonic anhydrase enzyme. Which of the following should be the effect of this drug?,Decrease in Vmax,Decrease in Km,Decrease in both Km and Vmax,No change in Vmax,0,multi,"Enzyme inhibition is of 3 types: Type of inhibition Km Vmax Competitive inhibition Increases No change Non competitive inhibition No change Decreases Uncompetitive inhibition Decreases Decreases In question non competitive inhibitor is given, so answer is decrease in Vmax.",Pharmacology,AIIMS 2018,validation,"{
    ""Correct answer"": ""A"",
    ""Reasoning"": ""Acetazolamide, as a non-competitive inhibitor of carbonic anhydrase, decreases the Vmax (maximum velocity) of the enzyme reaction without affecting the Km (Michaelis constant), which represents the binding affinity of the enzyme for its substrate. This is characteristic of non-competitive inhibition, where the inhibitor binds to a site other than the active site, reducing the enzyme's overall activity.""
}",A,"Acetazolamide, as a non-competitive inhibitor of carbonic anhydrase, decreases the Vmax (maximum velocity) of the enzyme reaction without affecting the Km (Michaelis constant), which represents the binding affinity of the enzyme for its substrate. This is characteristic of non-competitive inhibition, where the inhibitor binds to a site other than the active site, reducing the enzyme's overall activity.",A,1.0,0.49484082812393454,0.6112923646806965,0.0075641659522252104,0.3426573426573427,0.23854452389148634,1,0.33897984506113704
59ade17d-2139-4c4b-b0b5-ec6d6cf3c073,Propranolol is drug of choice for -,Ulcerated infantile hemangioma,Lymphangioma,Pyogenic granuloma,Capillary malformation,0,single,"Ans. A. Ulcerated infantile hemangiomaRef: <a href="" hemangiomas (IHs) are the most common benign pediatric soft-tissue tumors.</li>Ulceration--the most frequent complication of IH--tends to heal poorly and is associated with pain, bleeding, infection, and scarring.Mainstay treatment modalities include propranolol (b-blocker) and coicosteroids, whose effectiveness is countered by a need for long-term medication and risk of systemic adverse effects and ulcer recurrence.",Pharmacology,,validation,"{
    ""Correct answer"": ""A"",
    ""Reasoning"": ""Propranolol is the drug of choice for ulcerated infantile hemangioma. It has been shown to be effective in treating infantile hemangiomas, particularly those that are problematic due to their location or size, or those that have ulcerated, by reducing their size and promoting involution.""
}",A,"Propranolol is the drug of choice for ulcerated infantile hemangioma. It has been shown to be effective in treating infantile hemangiomas, particularly those that are problematic due to their location or size, or those that have ulcerated, by reducing their size and promoting involution.",A,1.0,0.638794881603677,0.7986542805161237,0.6441283780830512,0.3028846153846154,0.23642254463095266,1,0.524176940043684
8b72fc76-d0bf-4cd2-b7dc-05d030560c52,All are Gp lIbilIla inhibitors except:,Prasugrel,Abciximab,Tirofiban,Eptifibatide,0,multi,"Ans: A. Prasugrel(Ref Goodman Gilman 13/e p595, 12/e p870; Katzung 13/e p595, 12Ie p612; KDT 7/e p631)Prasugrel reduce platelet aggregation by inhibiting the ADP pathway of platelets. It irreversibly blocks the ADP receptor on platelets.Targets for platelet inhibitory drugs:Inhibition of prostaglandin synthesis (aspirin).Inhibition of ADP- induced platelet aggregation (clopidogrel, prasugrel, ticlopidine).Blockade of glycoprotein Ilb/IIIa receptors on platelets (abciximab, tirofiban, and eptifibatide). Dipyridamole & cilostazol - Additional antiplatelet drugs.",Pharmacology,,validation,"{
    ""Correct answer"": ""B"",
    ""Reasoning"": ""Abciximab is a GPIIb/IIIa inhibitor, but it is a monoclonal antibody, whereas the others are small molecules. Prasugrel is actually a P2Y12 inhibitor, not a GPIIb/IIIa inhibitor, but among the given options, Abciximab is the one that stands out for being a monoclonal antibody, however the question is about GP IIb/IIIa inhibitors, Prasugrel is the one that does not belong to this class.""
}",B,"Abciximab is a GPIIb/IIIa inhibitor, but it is a monoclonal antibody, whereas the others are small molecules. Prasugrel is actually a P2Y12 inhibitor, not a GPIIb/IIIa inhibitor, but among the given options, Abciximab is the one that stands out for being a monoclonal antibody, however the question is about GP IIb/IIIa inhibitors, Prasugrel is the one that does not belong to this class.",A,0.0,0.35363658299147255,0.764666780343114,0.06442595137381724,0.2033351264120495,0.14466982570293596,1,0.30614685336467784
45ea4d89-40f7-42af-8f94-b4dc1e9a5466,"While assessing the efficacy of a newly developed drug in comparison to placebo, the 95% confidence interval in clinical trials is used to check for:",Efficacy of the drug,Non-efficacy of the drug,Both efficacy and non-efficacy of the drug,Either efficacy or non-efficacy of the drug,0,multi,Answer- a (efficacy of the drug),Pharmacology,,validation,"{
    ""Correct answer"": ""A"",
    ""Reasoning"": ""The 95% confidence interval is used to check for efficacy of the drug, as it indicates the range of values within which the true effect of the drug is likely to lie, helping to determine if the drug is statistically significantly more effective than placebo.""
}",A,"The 95% confidence interval is used to check for efficacy of the drug, as it indicates the range of values within which the true effect of the drug is likely to lie, helping to determine if the drug is statistically significantly more effective than placebo.",A,1.0,0.6339919303674378,0.5896742868489877,0.0018587787502975103,0.38009049773755665,0.657237078514527,1,0.45257051444376123
b57b3bed-fda6-48e7-9af4-f72d5a4687d9,Pegloticase is used in,Chronic gout,Paralytic ileus,Psoriatic ahritis,Rheumatoid ahritis,0,single,"Pegloticase - It is recombinant uricase, an enzyme which oxidises uric acid to highly soluble allantoin, that is easily excreted by kidney. Humans lack this enzyme. In this preparation, the enzyme has been coupled with methoxy polyethylene glycol (mPEG) which serves to prolong its sojourn in the body, permitting i.v. infusion of the drug to be given every 2 weeks. It is indicated only in rare cases of refractory symptomatic gout because it is immunogenic and carries high risk of infusion reactions, including anaphylaxis.",Pharmacology,AIIMS 2019,validation,"{
    ""Correct answer"": ""A"",
    ""Reasoning"": ""Pegloticase is a recombinant uricase enzyme used to treat chronic gout in adults, as it breaks down uric acid. It's specifically indicated for patients with severe, treatment-resistant gout.""
}",A,"Pegloticase is a recombinant uricase enzyme used to treat chronic gout in adults, as it breaks down uric acid. It's specifically indicated for patients with severe, treatment-resistant gout.",A,1.0,0.7887515702454844,0.9676056491858842,0.3302804798629655,0.4251012145748989,0.2547983214521497,1,0.5533074470642766
1f93c541-baaf-40f2-bf91-31be29732da2,Treatment of choice for anaphylactic shock is:,Adrenaline 0.5 mL of 1:1000 solution by intramuscular route,Adrenaline 1 mL of 1:10000 by intravenous route,Atropine 3 mg intravenously,Adenosine 12 mg intravenously,0,single,"DOC is adrenaline.Route is intramuscular > subcutaneous.Dose: 0.5 ml of 1:1000(1mg/ml solution).This dose is repeated once gain within 10 minutes.If it's still not improving; then intravenous 1:10,000 dose is given.",Pharmacology,AIIMS 2017,validation,"{
    ""Correct answer"": ""A"",
    ""Reasoning"": ""Adrenaline is the first-line treatment for anaphylactic shock. The recommended dose is 0.5 mL of 1:1000 solution administered intramuscularly, which helps to rapidly increase blood pressure, relieve bronchospasm, and improve cardiac function.""
}",A,"Adrenaline is the first-line treatment for anaphylactic shock. The recommended dose is 0.5 mL of 1:1000 solution administered intramuscularly, which helps to rapidly increase blood pressure, relieve bronchospasm, and improve cardiac function.",A,1.0,0.6735126327037607,0.8370139143172723,0.3727838038084919,0.7107692307692308,0.49356650144782,1,0.6175292166093151
b8621196-05ba-414e-a112-0b48be3fcd7c,Which of the following diuretic can be given in mild to moderate hypeension?,Potassium sparing diuretic,Osmotic diuretic,Thiazide diuretic,Loop diuretic,2,single,"Ans: C. Thiazide diureticThiazide diuretics :Given in mild to moderate hypeension.Low-dose thiazide diuretics used alone or in combination with other antihypeensive drugs.Safe, efficacious, inexpensive & reduce clinical events. MOA:Inhibits Na/Cl- pump in DCT a Increases sodium excretion.In long term - Acts as vasodilators.Provide additive blood pressure-lowering effects (On combination with beta blockers, ACE-I, ARBs).Drug of Choicein HypeensionConditionDrug of ChoiceHypeensionThiazidesHypeension with BPHPrazosinHypeension with diabetes mellitusACE inhibitorsHypeension with ischemic hea disease (angina)Beta-blockersHypeension with chronic kidney diseaseACE inhibitorsHypeension in pregnancyAlpha-methyldopaHypeensive emergenciesNicardipine + EsmololHypeensive emergencies in cheese reactionPhentolamineHypeensive emergencies in clonidine withdrawalPhentolamineHypeensive emergencies in aoic dissectionNitroprusside + EsmololHypeensive emergencies in pregnancyLabetalol(Ref: Harrison 19/e p1623).",Pharmacology,,validation,"{
    ""Correct answer"": ""C"",
    ""Reasoning"": ""Thiazide diuretics are commonly used in mild to moderate hypertension due to their ability to reduce blood volume and peripheral resistance, making option C the correct choice.""
}",C,"Thiazide diuretics are commonly used in mild to moderate hypertension due to their ability to reduce blood volume and peripheral resistance, making option C the correct choice.",C,1.0,0.4187517557289336,0.6732665385342913,0.39719478249563395,0.2809364548494983,0.09977561192641606,1,0.37398502870695466
cafc0a38-bb29-4271-a180-95433a85392c,Prucalopride drug is ?,5HT4 agonist,5HT2b agonist,5HT2b antagonist,5HT2a agonist,0,single,"Ans. A. 5HT4 agonist* Prucalopride is a drug acting as a selective, high affinity 5-HT4 receptor agonist which targets the impaired motility associated with chronic constipation, thus normalizing bowel movements.* Approved for use in Europe in 2009.* Prucalopride, a first in class dihydro-benzofuran-carboxamide, is a selective, high affinity serotonin (5-HT4) receptor agonist with enterokinetic activities.* Prucalopride alters colonic motility patterns serotonin 5-HT4 receptor stimulation: it stimulates colonic mass movements, which provide the main propulsive force for defecation.* The observed effects are exeed highly selective action on 5-HT4 receptor.* Prucalopride has >150-fold higher affinity for 5-HT4 receptors than for other receptors.",Pharmacology,,validation,"{
    ""Correct answer"": ""A"",
    ""Reasoning"": ""Prucalopride is a 5HT4 agonist, which means it acts on the 5-HT4 receptors in the body. This action is primarily used to enhance gastrointestinal motility, making it useful in the treatment of chronic constipation.""
}",A,"Prucalopride is a 5HT4 agonist, which means it acts on the 5-HT4 receptors in the body. This action is primarily used to enhance gastrointestinal motility, making it useful in the treatment of chronic constipation.",A,1.0,0.7122329026172007,0.9743862672323623,1.0,0.406670252824099,0.24334435556191228,1,0.667326755647115
c3b4d610-571b-4e86-be27-d41b8b2efc65,Major determinant of loading dose of a drug is,Half life,Clearance,Volume of distribution,Bioavailability,2,single,LOADING DOSE = Vd * target plasma concentration MAINTENANCE DOSE = Clearance * target plasma concentration,Pharmacology,AIIMS 2018,validation,"{
    ""Correct answer"": ""C"",
    ""Reasoning"": ""The volume of distribution (Vd) is the major determinant of a drug's loading dose, as it affects how the drug distributes throughout the body. A higher Vd requires a larger loading dose to achieve the desired plasma concentration.""
}",C,"The volume of distribution (Vd) is the major determinant of a drug's loading dose, as it affects how the drug distributes throughout the body. A higher Vd requires a larger loading dose to achieve the desired plasma concentration.",C,1.0,0.42152462790544676,0.5945172424604692,0.02333983097796831,0.5701357466063349,0.47414450662795915,1,0.41673239091563563
5891372b-60e8-4a7c-b773-48598b2712e3,All of the following are potentially serious side effects of thioamide group of antithyroid drugs except:,Hepatic dysfunction,Severe rash,Agranulocytosis,Anaphylaxis,3,multi,"Ans: D. Anaphylaxis(Ref. Goodman Gilman 12/e p1149; Katzung 13/e p671, 12/e p688)Adverse effects of anti-thyroid drugs:Most serious reaction: AgranulocytosisMC reaction: Mild, purpuric, uicarial papular rash.Less frequent complications: Pain & stiffness in joints, paresthesias, headache, skin pigmentation & loss of hair.ANCAs in -50% of patients receiving propylthiouracil.Cholestatic jaundice - More common with methimazole than propylthiouracil.Propylthiouracil-associated hepatic failure.",Pharmacology,,validation,"{
    ""Correct answer"": ""D"",
    ""Reasoning"": ""Anaphylaxis is not typically associated with thioamide antithyroid drugs. Agranulocytosis, hepatic dysfunction, and severe rash are known side effects, particularly with medications like methimazole and propylthiouracil.""
}",D,"Anaphylaxis is not typically associated with thioamide antithyroid drugs. Agranulocytosis, hepatic dysfunction, and severe rash are known side effects, particularly with medications like methimazole and propylthiouracil.",D,1.0,0.6148934827244703,0.9506277642137065,0.2005875738793114,0.31952662721893477,0.13382472182324676,1,0.44389203397193394
82356aae-5bd4-4503-acab-5f70c0db6bee,Idiosyncratic side-effects of carbamazepine are all except:,Steven-Johnson syndrome,Agranulocytosis,Rash,Blurred vision,3,multi,"Answer- D. Blurred visionDiplopia (not the blurring of vision) is a dose related side effect of carbamazepine, while others are idiosyncratic, reactions.""The most common dose-related adverse effects of carbamazepine are diplopia and ataxia. The diplopia often occursfirst and may last less than an hour during a paicular time of day",Pharmacology,,validation,"{
    ""Correct answer"": ""D"",
    ""Reasoning"": ""Idiosyncratic side-effects of carbamazepine include rare but severe reactions like Steven-Johnson syndrome, agranulocytosis, and rash. Blurred vision is a dose-related side-effect, not idiosyncratic, making it the exception among the given options.""
}",D,"Idiosyncratic side-effects of carbamazepine include rare but severe reactions like Steven-Johnson syndrome, agranulocytosis, and rash. Blurred vision is a dose-related side-effect, not idiosyncratic, making it the exception among the given options.",D,1.0,0.6361230768292875,0.7660217646771373,0.6138220356522572,0.6127320954907162,0.36184129352197153,1,0.598108053234274
f14171b9-69fe-4e7f-b004-40f2eb8d4b8c,All of these are G2 phase blockers except:,Etoposide,Topotecan,Paclitaxel,Daunorubicin,2,multi,"Ans: C. Paclitaxel(Ref: Goodman Gilman 121e p1708; Katzung 13/e p932, 12Ie p963; KDT 7/e p865)Paclitaxel:Taxane, which act by causing disruption of the cell's microtubule function by stabilizing microtubule formation.Acts on the M-phase of cell division.Binds specifically to the P-tubulin subunit of microtubules and antagonizes the disassembly of this key cvtoskeletal protein, with the result that bundles of micro-tubules and aberrant structures derived from microtubules appear in the mitotic phase of the cell cycle.Arrest in mitosis follows.",Pharmacology,,validation,"{
    ""Correct answer"": ""C"",
    ""Reasoning"": ""Paclitaxel is a G2/M phase blocker, not a G2 phase blocker. It works by stabilizing microtubules, preventing cell division. Etoposide, Topotecan, and Daunorubicin are G2 phase blockers, interfering with DNA replication and cell cycle progression.""
}",C,"Paclitaxel is a G2/M phase blocker, not a G2 phase blocker. It works by stabilizing microtubules, preventing cell division. Etoposide, Topotecan, and Daunorubicin are G2 phase blockers, interfering with DNA replication and cell cycle progression.",C,1.0,0.4926124629604631,0.6020238424892619,0.21568520498957608,0.42990074441687354,0.23944963865533808,1,0.3959343787023025
27a7c775-991f-4c8d-8ba3-3783c3bf92db,All of the following drugs require dose reduction in renal failure except?,Amphotericin B,Vancomycin,Gentamicin,Doxycycline,3,multi,"Those drugs which are secreted in bile do not require dose reduction in renal disease. Doxycycline is secreted in bile, so it is safe in renal failure Drugs (commonly asked) safe in renal diseases include: Safe (Cef): Cefoperazone, Ceftriaxone In The: Tigecycline R: Rifampicin E: Erythromycin N: Nafcillin A: Ampicillin L: Lincosamides (Clindamycin) Disease: Doxycycline",Pharmacology,AIIMS 2018,validation,"{
    ""Correct answer"": ""D"",
    ""Reasoning"": ""Doxycycline is primarily metabolized by the liver and excreted into the bile, thus not requiring dose reduction in renal failure, unlike the other options which are excreted by the kidneys.""
}",D,"Doxycycline is primarily metabolized by the liver and excreted into the bile, thus not requiring dose reduction in renal failure, unlike the other options which are excreted by the kidneys.",D,1.0,0.5444562138430902,0.9537868992194269,0.4069522012951197,0.5131221719457014,0.40013575179010735,1,0.563690647618689
28b7a6ea-c657-4da7-81dc-88457a064655,Which of the following is not used in osteoporosis?,Milnacipran,PTH,Strontium ranelate,Denosumab,0,single,"Ans: A. Milnacipran(Ref. Goodman Gilman 12/e p1299; Katzung 13/e p761-762, 12/e p775; Harrison 19/e p2493, 18/c' p3120; Apley 9/e p /3 I-133)Milnacipran:Serotonin-norepinephrine reuptake inhibitor (SNRI).Approved for treatment of pain in fibromyalgia, not in osteoporosis.Drugs useful in OsteoporosisInhibit Bone ResorptionStimulates Bone Both actionBisphosphonates: Alendronate, risedronate & etidronateCalcium receptor agonist: CinacalcetCalcitoninSERMs: Tamoxifen, raloxifeneGallium nitrateRANKL inhibitors: DonesumabTeriparatideCalciumCalcitriolFluorideStrontium ranelate",Pharmacology,,validation,"{
    ""Correct answer"": ""A"",
    ""Reasoning"": ""Milnacipran is an antidepressant, not used in osteoporosis treatment. Options B, C, and D are used to treat osteoporosis: PTH (parathyroid hormone) regulates bone formation, Strontium ranelate has anti-resorptive and formation effects, and Denosumab inhibits osteoclast formation.""
}",A,"Milnacipran is an antidepressant, not used in osteoporosis treatment. Options B, C, and D are used to treat osteoporosis: PTH (parathyroid hormone) regulates bone formation, Strontium ranelate has anti-resorptive and formation effects, and Denosumab inhibits osteoclast formation.",A,1.0,0.3627122038478672,0.744235337739096,0.8359689767852331,0.32002902757619744,0.213782701281181,1,0.49534564944591486
a30f9a2b-52f0-4880-980d-d56de2a88910,"Among the following propeies of dopamine, which of them is not helpful in acute shock?",Alpha-1 agonist action leading to peripheral vasoconstriction,Increase in renal perfusion due to agonist action on DI receptors,Releases noradrenaline and causes positive inotropic effect,Direct action on hea beta-1 receptors,1,single,"Ans: B. Increase in renal perfusion due to agonist action on DI receptors(Ref: Goodman Gilman 13Ie p1062, 12/e p355; KDT 71e p134, 6Ie p507)Dopamine at low concentrations (2 to 5 mug/kg per minute) primarily acts on vascular D, receptors, especially in the renal, mesenteric, and coronary beds.Increased renal perfusion caused by dopamine due to DI agonism (at low doses) doesn't improves survival in acute shock.",Pharmacology,,validation,"{
    ""Correct answer"": ""B"",
    ""Reasoning"": ""In acute shock, increasing renal perfusion (option B) may not be immediately helpful as the primary goal is to restore systemic blood pressure and perfusion of vital organs. Options A, C, and D all contribute to increasing blood pressure and cardiac output, which are critical in managing acute shock.""
}",B,"In acute shock, increasing renal perfusion (option B) may not be immediately helpful as the primary goal is to restore systemic blood pressure and perfusion of vital organs. Options A, C, and D all contribute to increasing blood pressure and cardiac output, which are critical in managing acute shock.",B,1.0,0.47846606468423997,0.6250053786032994,0.2698128441223843,0.40384615384615374,0.3385801646224473,1,0.42314212117570493
5aeb3b7a-9012-4472-a233-740ba0f1dac5,Which of the following disease modifying anti-rheumatoid drugs acts by increasing extracellular adenosine?,Leflunomide,Hydroxychloroquine,Azathioprine,Methotrexate,3,single,"Answer-D. Methotrexate""Methotrexate is the DMARD of choicefor the treatment of RA and is the anchor drug for most combination therapies.At the dosages ased for lhe treatment of RA, methotrexale has been shown to stimulate adenosine release from cells, producing an anti-inflammatory effect.Methotrexate (MTX) is a folic acid analog that binds with high affinity to the active catalytic site of dihydrofolate reductase (DHFR).",Pharmacology,,validation,"{
    ""Correct answer"": ""D"",
    ""Reasoning"": ""Methotrexate acts by increasing extracellular adenosine, which has anti-inflammatory effects. Adenosine inhibits inflammatory cell activation and promotes apoptosis, contributing to its disease-modifying effects in rheumatoid arthritis.""
}",D,"Methotrexate acts by increasing extracellular adenosine, which has anti-inflammatory effects. Adenosine inhibits inflammatory cell activation and promotes apoptosis, contributing to its disease-modifying effects in rheumatoid arthritis.",D,1.0,0.6132004030957446,0.7561899603108508,0.5631685861070068,0.3060728744939271,0.1458344521521355,1,0.47689325523193304
fbaace6c-2dbd-458f-a1b6-8e831e7811fa,Which of these statements depicts vasomotor reversal of Dale?,Propranolol followed by adrenaline,Propranolol followed by noradrenaline,Decrease in hea rate on adrenaline administration after phentolamine has been given,Noradrenaline followed by propranolol,2,multi,"Ans: C. Decrease in hea rate on adrenaline administration after phentolamine has been given (Ref: KDT 7/e e p131, 140).This was first demonstrated by Sir HH Dale (1913) and is called vasomotor reversal of Dale.Blockade of vasoconstrictor alpha-1 (also alpha-2) receptors reduces peripheral resistance and causes pooling of blood in capacitance vessels a venous return and cardiac output are reduced a Fall in BP.Postural reflex is interfered with a marked hypotension occurs on standing a dizziness and syncope. Hypovolemia accentuates the hypotension.Decrease in hea rate on adrenaline administration after phentolamine has been given depicts vasomotor reversal of Dale.The alpha-blocker abolishes the pressor action of adrenaline (injected IV in animals), which then produces only fall in BP due to beta-2 mediated vasodilatation.",Pharmacology,,validation,"{
    ""Correct answer"": ""C"",
    ""Reasoning"": ""Vasomotor reversal of Dale occurs when alpha-adrenergic receptors are blocked, causing adrenaline to induce vasodilation instead of vasoconstriction. This is seen as a decrease in heart rate on adrenaline administration after phentolamine (an alpha-blocker) has been given, making option C the correct choice.""
}",C,"Vasomotor reversal of Dale occurs when alpha-adrenergic receptors are blocked, causing adrenaline to induce vasodilation instead of vasoconstriction. This is seen as a decrease in heart rate on adrenaline administration after phentolamine (an alpha-blocker) has been given, making option C the correct choice.",C,1.0,0.6211370518073757,0.7668752325039566,0.9876821615523766,0.6057692307692308,0.4137602352150014,1,0.6790447823695882
5fecb77f-66cc-4650-8201-3759bda2a213,"A drug X was given continuous intravenous infusion at 1.6 mg/min. The clearance of the drug is 640 mL/min. With a half-life of 1.8 hours, what would be the steady state plasma concentration of drug?",0.002 mg/mL,0.004 trig/mL,2.88 mg/mL,3.55 mg/mL,0,single,Answer- A. 0.002 mg/mLCpss is directly propoional to the dose rate & inversely propoional to the clearance of drug.Cpss = Dose rate/clearanceDose rate= 1.6 mgiml; Clearance= 640 ml/minCpss = 1.61640 = 0.0025 mg/ml = 0.002 mg/ml,Pharmacology,,validation,"{
    ""Correct answer"": ""A"",
    ""Reasoning"": ""At steady state, the infusion rate equals the clearance rate. The steady state concentration (Css) is calculated as infusion rate / clearance. Css = 1.6 mg/min / 640 mL/min = 0.0025 mg/mL, which is closest to option A. This calculation assumes that the volume of distribution is not required for the answer.""
}",A,"At steady state, the infusion rate equals the clearance rate. The steady state concentration (Css) is calculated as infusion rate / clearance. Css = 1.6 mg/min / 640 mL/min = 0.0025 mg/mL, which is closest to option A. This calculation assumes that the volume of distribution is not required for the answer.",A,1.0,0.7318239758176277,0.6744471949206777,0.08666221252119763,0.7141700404858299,0.38278502871732395,1,0.5179776904925314
2b110e57-8338-4189-86e2-cbea7d761c30,A diabetic patient presented with uncontrolled blood sugar level. He has history of pancreatitis and family history of urinary bladder carcinoma. He does not want to take injectable drugs. Which of the following drug can be added to control his blood sugar?,Liraglutide,Sitagliptin,Canagliflozin,Pioglitazone,2,single,"Linaglutide(-ide) is a peptide, so not given orally. It is a GLP 1(incretin) analogue and it can cause pancreatitis.Sitagliptin is a DPP 4(dipeptidyl peptidase 4) inhibitor; can cause pancreatitis.Pioglitazone(PPAR- gamma agonist) can cause urinary bladder carcinoma; so can't be given.So, canagliflozin (SGLT 2 inhibitor) can be added.",Pharmacology,AIIMS 2017,validation,"{
    ""Correct answer"": ""B"",
    ""Reasoning"": ""Sitagliptin is an oral DPP-4 inhibitor, suitable for a patient who doesn't want injectables. It's a better choice given the patient's history of pancreatitis, as it has a lower risk of pancreatitis compared to other options like Liraglutide, and no increased risk of bladder cancer like Pioglitazone.""
}",B,"Sitagliptin is an oral DPP-4 inhibitor, suitable for a patient who doesn't want injectables. It's a better choice given the patient's history of pancreatitis, as it has a lower risk of pancreatitis compared to other options like Liraglutide, and no increased risk of bladder cancer like Pioglitazone.",C,0.0,0.7349242408741251,0.7559769817434433,0.1554387311957239,0.3657474600870828,0.27943846518115306,1,0.4583051758163056
8788091c-a8ef-4155-a7a3-8e85d643f856,"A patient presented with acute exacerbation of bronchial asthma. Salbutamol inhalation didn't improve the condition of the patient. So, intravenous coicosteroids and aminophylline were added and the condition improved. What is the mechanism of action of coicosteroids in this condition?",They cause bronchodilatation when given with xanthines,They increase bronchial responsiveness to salbutamol,They increase the action of aminophylline on adenosine receptors,They increase the mucociliary clearance,1,single,"Ans. b. They increase bronchial responsiveness to salbutamol Coicosteroids has a dual effect in acute asthma with an early facilitator effect on airway beta-2 adrenoreceptor sensitivity and a later effect on airway inflammation, which fuher emphasizes the need fir coicosteroids to he administered as early as possible during an acute asthma attack.""he molecular mechanism of action of coicosteroids involves several effects on the inflammatory process. The major effect of coicosteroids is to switch off the transcription of multiple activated genes that encode inflammatory proteins such as cytokines, chemokines, adhesion molecules, and inflammatory enzymes. This effect involves several mechanisms, including inhibition of the transcription factor NF-KB, but an impoant mechanism is recruitment of HDAC2 to the inflammatory gene complex, which reverses the histone acetylation associated with increased gene transcription. Coicosteroids also activate anti-inflammatory genes, such as mitogen-activated protein (MAP) kinase phosphatase-1, and increase the expression of IQ-receptors. Most of the metabolic and endocrine side effects of coicosteroids are also mediated through transcriptional activation.",Pharmacology,,validation,"{
    ""Correct answer"": ""B"",
    ""Reasoning"": ""Corticosteroids reduce inflammation and increase bronchial responsiveness to beta-2 agonists like salbutamol, explaining the improved condition.""
}",B,"Corticosteroids reduce inflammation and increase bronchial responsiveness to beta-2 agonists like salbutamol, explaining the improved condition.",B,1.0,0.654050279180154,0.8322192131336407,0.454615180205901,0.18238213399503705,0.05281977830148489,1,0.43521731696324356
d42801fb-0724-4137-b72a-3eb0d50fc9f1,Which of the following is a schedule X drug?,Thalidomide,Colistin,Ketamine,Halothane,2,single,"Ans. C. Ketamine* The following are the Schedule X drugs mentioned in the Drugs and Cosmetics Rules 1945: Amobarbital, Amphetamine, Barbital, Cyclobarbital, Dexamphetamine, Ethchlorvynol, Glutethimide, Meprobamate, Methamphetamine, Methylphenidate, Methylphenobarbital, Phencyclidine, Phenmetrazine, Secobarbital.",Pharmacology,,validation,"{
    ""Correct answer"": ""A"",
    ""Reasoning"": ""Thalidomide is a schedule X drug due to its potential for severe birth defects, strict controls are in place. It's used under strict regulations for conditions like multiple myeloma.""
}",A,"Thalidomide is a schedule X drug due to its potential for severe birth defects, strict controls are in place. It's used under strict regulations for conditions like multiple myeloma.",C,0.0,0.2732936811658193,0.4836995601173435,0.030891449540279125,0.31265508684863524,0.23889380728454823,1,0.2678867169913251
17ca6005-346f-4f14-b1a3-430d3667d7f0,Black deposits on conjunctiva in a patient with glaucoma are seen with the use of:,Prostaglandins,Carbonic anhydrase inhibitors,Epinephrine,Beta blocker,2,single,"Ans: C. Epinephrine(Ref: Goodman Gilman 12/e p286, 326; Katzung 13/e p161, 12/e p160; The Cornea by Smolin and Thoft's/p504)Black deposits on conjunctiva in a patient with glaucoma are seen with use of epinephrine. Latanoprost is associated with iris hyperpigmentation.Epinephrine is unstable in alkaline solution; when exposed to air or light, it turns pink from oxidation to adrenochrome and then brown from formation of polymers.",Pharmacology,,validation,"{
    ""Correct answer"": ""C"",
    ""Reasoning"": ""Epinephrine can cause adrenochrome deposits, which appear as black pigmentation on the conjunctiva, especially in patients with glaucoma who use epinephrine eye drops for prolonged periods.""
}",C,"Epinephrine can cause adrenochrome deposits, which appear as black pigmentation on the conjunctiva, especially in patients with glaucoma who use epinephrine eye drops for prolonged periods.",C,1.0,0.6484680380400613,0.9124148238732215,0.5468472005454559,0.4945054945054945,0.2231873158478101,1,0.5650845745624087
524d41bf-ef51-49b4-8662-dcaf2c2798fb,A diabetic and hypeensive patient taking several drugs presented with septicemia. Serum creatinine levels are 5.7 mg/dL. Which of the following drug should be stopped?,Insulin,Metoprolol,Linagliptin,Metformin,3,single,Serum creatinine levels are raised indicating renal failure. In renal failure and hepatic failure --> Metformin is C/I as it |ses the risk of developing lactic acidosis. Contraindicated in patients with an eGFR below 30 mL/minute/1.73 m2. eGFR should be measured annually for patients taking metformin therapy. eGFR is preferred over serum creatinine concentration to assess renal function for a person taking metformin therapy Linagliptin is a DPP-4 inhibitor. Metoprolol is a b blocker.,Pharmacology,AIIMS 2017,validation,"{
    ""Correct answer"": ""D"",
    ""Reasoning"": ""Metformin should be stopped due to the patient's elevated serum creatinine levels, indicating impaired renal function. Metformin is contraindicated in renal impairment due to the risk of lactic acidosis.""
}",D,"Metformin should be stopped due to the patient's elevated serum creatinine levels, indicating impaired renal function. Metformin is contraindicated in renal impairment due to the risk of lactic acidosis.",D,1.0,0.8120112596236159,1.0,0.8936942418291405,0.5384615384615385,0.5061470070229315,1,0.7500628093874453
c2966f39-a3e7-464d-9048-937bf330c794,Antimalarial drug used for causal prophylaxis act at which stage of developmental cycle,Gametogony,Erythrocytic schizogony,Pre-erythrocytic schizogony,Exo-erythrocytic schizogony,2,single,Ans. C. Pre-erythrocytic schizogonyPre-erythrocytic schizogony* Occurs inside the parenchymal cells of liver.* Merozoites are liberated into blood.* Drugs acting on this stage will prevent infection of RBC and clinical attack of malaria causal prophylaxis.* Drugs are* Proguanil & Tetracycline - for falciparum.,Pharmacology,,validation,"{
    ""Correct answer"": ""C"",
    ""Reasoning"": ""Causal prophylaxis targets the pre-erythrocytic stage, preventing the parasites from entering the erythrocytic cycle. Drugs like proguanil and atovaquone act at this stage, inhibiting parasite development before it reaches the bloodstream, thus preventing malaria infection.""
}",C,"Causal prophylaxis targets the pre-erythrocytic stage, preventing the parasites from entering the erythrocytic cycle. Drugs like proguanil and atovaquone act at this stage, inhibiting parasite development before it reaches the bloodstream, thus preventing malaria infection.",C,1.0,0.5668893284140443,0.6933854807558046,0.3854934600165168,0.5591715976331361,0.4113987060905053,1,0.5232677145820014
407d4eec-cf0b-460c-bcdb-cf0081ec8c5d,Methacholine acts at which receptor?,M1,M2,M3,M4,1,single,"Ans: B. M2Methacholine is an M2 receptor agonist.ParameterM1M2M3Agonists (Relatively selective)Oxotremorine, MCN-343AMethacholineBethanecholAntagonists (Relatively selective)Pirenzepine, TelenzepineMethoctramine, TripitramineDarifenacin, Solifenacin",Pharmacology,,validation,"{
    ""Correct answer"": ""B"",
    ""Reasoning"": ""Methacholine acts at M2 muscarinic receptors, found in the heart, causing a decrease in heart rate. It is a non-selective muscarinic agonist but has a preference for M2 receptors.""
}",B,"Methacholine acts at M2 muscarinic receptors, found in the heart, causing a decrease in heart rate. It is a non-selective muscarinic agonist but has a preference for M2 receptors.",B,1.0,0.35768368917241344,0.7032296194246245,0.17223029390944933,0.29076923076923084,0.2652018635127184,1,0.35782293935768733
0ba46472-54a7-4bb9-9802-a0546e24cede,A bank employee felt depressed with no interest in activities came to AIIMS OPD. He was staed on Escitalopram. Which of these adverse effects cannot be explained with escitalopram?,Vivid dreaming,Anorgasmia,Sialorrhea,Nausea,2,single,"Ans. C. SialorrheaEscitalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRI).Improves your energy levels and feelings of well-being and decrease nervousness.Used to treat depression and anxiety.MOA: Works by helping to restore the serotonin balance in the brain.S/E:Headache, Nausea, Ejaculation disorder, Somnolence, Insomnia, Dry mouth, Constipation, Fatigue, Libido decreased, Inability to achieve orgasm, Gas (flatulence), Toothache, Weight gain, Menstrual disorder, Neck/shoulder pain, Runny nose & Flu-like syndrome.",Pharmacology,,validation,"{
    ""Correct answer"": ""C"",
    ""Reasoning"": ""Escitalopram is an SSRI, known for side effects like vivid dreaming, anorgasmia, and nausea. However, sialorrhea (excessive salivation) is not a common or expected side effect of escitalopram, making it the option that cannot be explained by escitalopram use.""
}",C,"Escitalopram is an SSRI, known for side effects like vivid dreaming, anorgasmia, and nausea. However, sialorrhea (excessive salivation) is not a common or expected side effect of escitalopram, making it the option that cannot be explained by escitalopram use.",C,1.0,0.4645917243381298,0.7240265245880555,0.1302637016353375,0.20534550195567147,0.19542556205346212,1,0.34393060291413124
fc3d5863-8850-4136-8bf9-8f7bb80ca2cb,Which of the following is not true for rifabutin as compared to rifampicin?,Rifabutin has the longer half-life than rifampicin,Rifabutin has lesser incidence of drug-interactions,Rifabutin is more efficacious against MAC as compared to rifampicin,Rifabutin is more efficacious for pulmonary TB as compared to rifampicin,3,multi,"Ans: D. Rifabutin is more efficacious for pulmonary TB as compared to rifampicin(Ref Goodman Gilman 12/e p1550, 1552, 1554, 1568; Katzung 12/e p845)Rifabutin:Stronger activity against Mycobacterium avium complex (compared to rifampicin).Ineffective against Mycobacterium tuberculosis. RifabutinRifampicin (Rifampin)RifapentineProtein binding 718597Oral 2068deg-tmax (hours)2.5-4.01.5-2.05.0-6.0degHalf-life (hours)32-67deg2-5deg14-18Intracellular/extracellular9524-60degAutoinduction40%deg38%20%CYP3A inductionWeakPronouncedModerateCYP3A substrateYesdegNoNo",Pharmacology,,validation,"{
    ""Correct answer"": ""D"",
    ""Reasoning"": ""Rifabutin is not more efficacious for pulmonary TB than rifampicin. Rifampicin is a key drug in TB treatment due to its potent bactericidal activity. Rifabutin is used as an alternative, especially in HIV patients, due to its lesser enzyme-inducing potential and efficacy against Mycobacterium avium complex (MAC).""
}",D,"Rifabutin is not more efficacious for pulmonary TB than rifampicin. Rifampicin is a key drug in TB treatment due to its potent bactericidal activity. Rifabutin is used as an alternative, especially in HIV patients, due to its lesser enzyme-inducing potential and efficacy against Mycobacterium avium complex (MAC).",D,1.0,0.5713518226715966,0.8747441691467873,0.1528091672369273,0.5294117647058825,0.5354718123533789,1,0.5327577472229146
4127528f-2cc3-44bc-b07e-446577f5018c,What is the dose of adrenaline in anaphylactic shock?,0.5 ml in 1:1000,0.5 ml in 1:10000,1 ml in 1:1000,1.5 ml in 1:1000,0,single,"Ans. A. 0.5 ml in 1:1000Severe hypersensitivity reactions, anaphylactic shockIM Injection:* Adults: The usual dose is 500 micrograms (0.5ml of adrenaline 1/1000). If necessary, this dose may be repeated several times at 5-minute intervals according to blood pressure, pulse and respiratory function.* Half doses of adrenaline may be safer for patients who are taking amitriptyline, imipramine or a beta blocker.Paediatric population:* The following doses of adrenaline 1/1,000 are recommended:AgeDoseOver 12 years0.5 mg IM (0.5ml 1:1000 solution)6 - 12 years0.3 mg IM (0.3ml 1:1000 solution)6 months - 6 years0.15 mg IM (0.15ml 1:1000 solution)Under 6 months0.01mg/kg IM (0.01ml/kg 1:1000 solution)* If necessary, these doses may be repeated at 5-15 -minute intervals according to blood pressure, pulse and respiratory function.",Pharmacology,,validation,"{
    ""Correct answer"": ""A"",
    ""Reasoning"": ""Adrenaline for anaphylactic shock is typically given as 0.5 ml of a 1:1000 solution intramuscularly, making option A the correct choice, based on standard emergency treatment protocols for anaphylaxis.""
}",A,"Adrenaline for anaphylactic shock is typically given as 0.5 ml of a 1:1000 solution intramuscularly, making option A the correct choice, based on standard emergency treatment protocols for anaphylaxis.",A,1.0,0.49061466110147145,0.6580849422928828,0.741276300971404,0.2506631299734747,0.13285550401156887,1,0.4546989076701603
1f6b3a83-ed5e-4d0e-90b3-f740ff95c763,All are used for postpaum hemorrhage except -,Misoprostol,Dinoprostone,Prostaglandin F2 alpha,Oxytocin,1,multi,"Ans. B. DinoprostonePostpaum hemorrhage, the loss of more than 500 mL of blood after delivery, occurs in up to 18 percent of bihs and is the most common maternal morbidity in developed countries. Dinoprostone:Naturally occurring prostaglandin E2 (PGE2). It has impoant effects in labour.It also stimulates osteoblasts to release factors which stimulates bone resorption by osteoclasts.As a prescription drug it is used as a vaginal suppository, to prepare the cervix for labour and to induce labour. Indication:For the termination of pregnancy during the second trimester (from the 12th through the 20th gestational week as calculated from the first day of the last normal menstrual period), as well as for evacuation of the uterine contents in the management of missed aboion or intrauterine fetal death up to 28 weeks of gestational age as calculated from the first day of the last normal menstrual period.In the management of nonmetastatic gestational trophoblastic disease (benign hydatidiform mole).Other indications include improving the cervical inducibility (cervical ""ripening"") in pregnant women at or near term with a medical or obstetrical need for labor induction, and the management of postpaum hemorrhage.",Pharmacology,,validation,"{
    ""Correct answer"": ""B"",
    ""Reasoning"": ""Dinoprostone is a prostaglandin E2 analog used for labor induction, not typically for postpartum hemorrhage. Misoprostol, prostaglandin F2 alpha, and oxytocin are all used to manage postpartum hemorrhage.""
}",B,"Dinoprostone is a prostaglandin E2 analog used for labor induction, not typically for postpartum hemorrhage. Misoprostol, prostaglandin F2 alpha, and oxytocin are all used to manage postpartum hemorrhage.",B,1.0,0.47011402384260037,0.7822023923462545,0.14623456048842973,0.22332506203473942,0.12434775049494429,1,0.34924475784139364
416729b9-8f0b-45d1-aa27-6674dacb9975,"At low infusion rates of 3-5 mcg/kg/min, what action is produced by dopamine?",Vasoconstriction,Increased renal blood flow,Increased cardiac contractility,Decreased blood pressure,1,single,"Ans: B. Increased renal blood flow(Ref: Goodman Gilman 12/e p355; KDT 7/e p134. 6/e p507)Action of dopamine:At low concentrations (2 to 5 mcg/kg per minute):Primarily acts on vascular D1 receptors.Mainly renal, mesenteric & coronary beds.By activating adenylyl cyclase a raising intracellular cyclic AMP concentrations.D1 receptor stimulation a Vasodilation.Increases in glomerular filtration rate, renal blood flow & Nat+ K+ - ATPase pump.",Pharmacology,,validation,"{
    ""Correct answer"": ""B"",
    ""Reasoning"": ""At low infusion rates of 3-5 mcg/kg/min, dopamine acts on dopamine receptors, producing vasodilation, particularly in the renal and mesenteric vessels, thereby increasing renal blood flow.""
}",B,"At low infusion rates of 3-5 mcg/kg/min, dopamine acts on dopamine receptors, producing vasodilation, particularly in the renal and mesenteric vessels, thereby increasing renal blood flow.",B,1.0,0.6531587750322804,0.9067745638811888,0.6136790874865384,0.6853146853146855,0.3804026660190493,1,0.6478659555467485
07c14e46-ad2b-4fde-8652-bd47b36e69ab,Vasopressin antagonist acts on which pa of the nephron?,Proximal convoluted tubule,Distal convoluted tubule,Coical collecting tubule,Medullary collecting duct,3,single,Answer- D (Medullary collecting duct)'The mechanism by which vasopressin exes its anti-diuretic effect is activated by V2 receptors and involves the inseion of aquaporin-2 into the apical (luminal) membranes at the principle cells of the collecting duct.',Pharmacology,,validation,"{
    ""Correct answer"": ""D"",
    ""Reasoning"": ""Vasopressin antagonists act on the medullary collecting duct, where vasopressin (ADH) normally increases water permeability, promoting water reabsorption. Antagonists inhibit this action, increasing water excretion.""
}",D,"Vasopressin antagonists act on the medullary collecting duct, where vasopressin (ADH) normally increases water permeability, promoting water reabsorption. Antagonists inhibit this action, increasing water excretion.",D,1.0,0.6024624516806697,0.6578778954892891,0.17616679766800558,0.2982248520710058,0.24141427535245857,1,0.3952292544522858
604ef1a2-7595-4718-9f8c-12292063e19f,Which of the following anti-tubercular drug can cause ophthalmological toxicity?,Isoniazid,Rifampicin,Ethambutol,Pyrazinamide,2,single,"Ethambutol side effect: causes Red Green color blindness (Ophthalmological toxicity) Isoniazid side effects: Neurotoxicity, Hepatotoxicity. Pyrazinamide side effects: Hyperuricemia (gouty ahritis). Rifampicin side effects: Hepatotoxicity, orange red urine and tears etc.",Pharmacology,AIIMS 2018,validation,"{
    ""Correct answer"": ""C"",
    ""Reasoning"": ""Ethambutol can cause ophthalmological toxicity, particularly optic neuritis, leading to blurred vision and color vision changes. This is a well-documented side effect of ethambutol, making it the correct choice.""
}",C,"Ethambutol can cause ophthalmological toxicity, particularly optic neuritis, leading to blurred vision and color vision changes. This is a well-documented side effect of ethambutol, making it the correct choice.",C,1.0,0.6309189527799024,0.6966977588383987,0.272129615361752,0.4766708701134931,0.3487829439710326,1,0.4850400282129158
